The National LGBT Health Education Center at The Fenway Institute Releases Important Documents About HIV Prevention

The National LGBT Health Education Center at The Fenway Institute has released two important documents to help both patients and clinicians better understand the use of important newly-approved HIV prevention methods.

The two guides provide an extensive overview of the use of HIV treatment medication for HIV-negative people at high risk of getting HIV that was recently approved by The Food & Drug Administration.  Known as “pre-exposure prophylaxis”—or PrEP—this medication is a once-a-day pill to be used in combination with condoms and other safer sex behavioral strategies to reduce risk.  Introducing the “PrEP Package” for Enhanced HIV Prevention: A Practical Guide for Clinicians is designed for use by clinicians whileProtecting Yourself from HIV through Pre-Exposure Prophylaxis (PrEP): What You Need to Know informs consumers about PrEP and how it works, as well as other ways they can work with their health care providers to protect themselves against HIV.

PrEP has shown efficacy with men who have sex with men (MSM) and heterosexual women and men. Biomedical prevention interventions such as PrEP have great potential, especially if coupled with traditional prevention approaches such as condom use, expanded testing, and linkage to treatment and care. Modeling demonstrates the most effective deployment of PrEP will be in combination with scaled-up HIV treatment of people who are known to be HIV-positive, as this was shown to reduce infections.

“The use of PrEP can prevent many new infections and could dramatically impact HIV transmission worldwide,” said Kenneth H. Mayer, MD, Medical Research Director and Co-Chair of The Fenway Institute at Fenway Health. “We at Fenway Health are delighted to have helped to demonstrate the utility of this approach for prevention and be in a position to help share this critically important information.”

In addition, The Fenway Institute will conduct a webinar on the latest HIV prevention innovations that can be used in primary care settings.  Antiretrovirals for HIV Prevention: PEP and PrEP in Clinical Practice will be sponsored by the National LGBT Health Education Center and conducted by Ken Mayer on Thursday, November 6, 2012 at 3:00 pm EST.

For more information and to download copies of these documents, or to register for the webinar on November 6, please visitwww.lgbthealtheducation.org.

For more than forty years, Fenway Health has been working to make life healthier for the people in our neighborhood, the LGBT community, people living with HIV/AIDS and the broader population.  The Fenway Institute at Fenway Health is an interdisciplinary center for research, training, education and policy development focusing on national and international health issues. Fenway’s Sidney Borum Jr. Health Center cares for youth and young adults ages 12 to 29 who may not feel comfortable going anywhere else, including those who are LGBT or just figuring things out; homeless or living on the streets; struggling with substance use or abuse; sex workers; or living with HIV/AIDS.

Comments

comments

Leave a Reply